Moisand Fitzgerald Tamayo Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.05M |
| 2 |
Pfizer
PFE
|
+$347K |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$297K |
| 4 |
Schwab US Mid-Cap ETF
SCHM
|
+$278K |
| 5 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$271K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$232K |
| 2 |
Schwab International Small-Cap Equity ETF
SCHC
|
+$143K |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$129K |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$76.4K |
| 5 |
Schwab U.S Small- Cap ETF
SCHA
|
+$76.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.3% |
| 2 | Communication Services | 1.09% |
| 3 | Financials | 1.07% |
| 4 | Energy | 1.02% |
| 5 | Technology | 0.96% |
Similar funds
Moisand Fitzgerald Tamayo's Q3 2017 Portfolio in Review
As of Q3 2017, Moisand Fitzgerald Tamayo held 329 positions worth $164M, up 12% from $147M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Moisand Fitzgerald Tamayo deployed $11.4M of net new capital in Q3 2017, opening 258 new positions and adding to 25 existing holdings. Its largest new stake was Pfizer: 10,811 shares worth $366K.
By sector, the portfolio is most concentrated in Healthcare at 1.3% of assets, up from 1% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $232K trimmed.
- Moisand Fitzgerald Tamayo's largest Q3 2017 buy was Pfizer: 10,811 shares worth $366K.
- Moisand Fitzgerald Tamayo added most to iShares Core S&P 500 ETF in Q3 2017, an estimated $2.05M increase.
- Moisand Fitzgerald Tamayo's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $232K.
- Moisand Fitzgerald Tamayo's ten largest holdings make up 59% of its $164M portfolio in Q3 2017.
- Moisand Fitzgerald Tamayo opened 258 new positions and closed 0 in Q3 2017.
- Moisand Fitzgerald Tamayo's portfolio value rose 12% quarter-over-quarter to $164M.
Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2017, filed 3 Nov 2017.